Baikuirui logo — company profile

Baikuirui

Founded 2021 Series A Total: $60.00M Biotechnology

General Information

Company Name Baikuirui
Founded Year 2021
Industries Biotechnology
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Baikuirui. To contact Baikuirui, visit biocreatech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Baikuirui compare?

A PDF of Baikuirui and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Baikuirui soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Baikuirui

Biocreatech, founded in 2021, is an innovative biotechnology firm known for its use of protein design and synthetic biology in developing cell factories. These factories are engineered to produce a wide array of products including drug intermediates, fine chemicals, functional peptides, and therapeutic proteins. Their unique approach involves integrating multiple proteins into molecular machines to essentially transform cells into efficient production facilities. The company recently received a significant boost with a Series A investment on 23rd April 2024, led by Guangdong Technology Financial Group and TriWise Capital. This investment is positioned to propel Biocreatech's cutting-edge technologies and further establish its foothold in the Biotechnology industry.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 2
Guangdong Technology Financial Group, TriWise Capital
23 Apr 2024
Seed Round Undisclosed 1
Xingtuo Capital
07 Sep 2022
Seed Round CNY50.00M 2
BioVenture, CASH Capital
17 Feb 2022
Angel Round CNY10.00M 3
Haitang Fund, Volcanic Stone Investment +1
16 Sep 2021

Baikuirui Alternatives & Competitors

View All Alternatives
Baikuirui vs
SyntheX
SyntheX United States

Targeting the undruggable with synthetic biology-based drug discovery platforms

Venture round
26 employees
Biotechnology, Health and Wellness
Baikuirui vs

Committed to Lifescience

10 employees
Biotechnology, Life Sciences
Baikuirui vs
Dima Biotechnology
Dima Biotechnology United States

Recombinant monoclonal antibodies and membrane proteins for drug discovery.

Angel
6 employees
Biotechnology, Health Care

FAQ About Baikuirui

Biocreatech is a biotechnology firm that employs protein design and synthetic biology to develop cell factories capable of producing various products such as drug intermediates, fine chemicals, functional peptides, and therapeutic proteins. They focus on integrating multiple proteins into molecular...
Baikuirui was founded in 2021.
Baikuirui operates in Biotechnology.
Baikuirui has completed 4 funding rounds, raising a total of $60.00M. The latest funding stage is Series A.
Top alternatives and competitors to Baikuirui include SyntheX, Pepmic Co., Ltd, Dima Biotechnology, BioPact, NexImmune, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Baikuirui and SyntheX are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Baikuirui, https://bouncewatch.com/company/baikuirui, updated 13 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes